Bay Colony Advisory Group, Inc D Sarepta Therapeutics, Inc. Transaction History

Bay Colony Advisory Group, Inc D

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$106.67 - $151.68 $224,753 - $319,589	-2,107 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$97.32 - $148.76 $272,496 - $416,528	-2,800 Reduced 57.06%	2,107 $230,000
Q3 2018 Nov 05, 2018	BUY	$115.31 - $161.51 $404,392 - $566,415	3,507 Added 250.5%	4,907 $793,000
Q2 2018 Aug 09, 2018	BUY	$71.74 - $153.69 $100,436 - $215,166	1,400 New	1,400 $185,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.